Stay Informed: Transforming Radiology with Structured Reporting and Data-Driven Approaches

Dive into our activities, projects, and product updates. Catch on the latest industry news and learn who we are as a company and as a team.

Creating evidence to tackle COVID-19

Our COVID-19 reading template is in use for two weeks, and its usage is multiplying. We are grateful for the close cooperation and feedback from existing and new mint Lesion™ users.

Our medical team went through all the available publications and created a reading template that can be used with ease by readers in your hospital or research center. As new papers and guidelines become available, we will update the reading template, retaining the structured data already collected.

mint Lesion™ extracts all primary data - including radiomics features - from images, and immediately links any measured value to its context and further related data of clinical significance. Together with clinical endpoints, the mineable data is ready for real-time analytics and AI.

Let mint Lesion™ assist you in generating the data and creating the evidence that will enable us to tackle COVID-19 jointly.

Request a demo

Related Resources

Related Resources

mint Lesion screenshot with PET evaluation, SUV, customized response criteria

Customizable reading templates for therapy response assessment

mint Lesion offers customizable reading templates for therapy response assessment in clinical care and research. Adapt parameters, define lesion…

AI lung nodules detection in contextflow and Lung-RADS in mint Lesion

Leverage Advanced AI-Driven Nodule Detection and Analysis for Comprehensive Patient Care

Discover the power of streamlined AI-driven lung screening with contextflow ADVANCE Chest CT integrated into mint Lesion. With automated lung nodule…

Image shows graphic related to study's research on iRECIST and RECIST

University Hospital Cologne: Comparison of iRECIST and RECIST 1.1 for Evaluating Immunotherapy in Melanoma and Non-Small Cell Lung Cancer

A retrospective study conducted at University Hospital Cologne compared two criteria for assessing therapeutic response to immunotherapy: iRECIST and…